Figure 3.

Number of undesirable drug–drug interaction at timepoints T0 and T1 by type and study arm (in the 969 patients able to be interviewed at the end of 1 year)

A2, drug class that includes ACE inhibitors, AT1-antagonists, and renin inhibitors; NSAID, nonsteroidal anti-inflammatory or antiphlogistic drug; OAC, oral anticoagulant; APD, antiplatelet drug

eTable 1a-1 https://www.aerzteblatt.de/callback/image.asp?id=121242

eTable 1a-2 https://www.aerzteblatt.de/callback/image.asp?id=121243

eTable 1b-1 https://www.aerzteblatt.de/callback/image.asp?id=121244

eTable 1b-2 https://www.aerzteblatt.de/callback/image.asp?id=121245